查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754098

生物材料市场报告（按类型（天然生物材料、金属生物材料、陶瓷生物材料、聚合物生物材料）、应用（神经病学、心臟病学、骨科、伤口护理、牙科、整形外科等）和地区）2025 年至 2033 年

Biomaterials Market Report by Type (Natural Biomaterial, Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial), Application (Neurology, Cardiology, Orthopedics, Wound Care, Dental, Plastic Surgery, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球生物材料市场规模达1,261亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到2,897亿美元，2025-2033年期间的复合年增长率（CAGR）为9.7%。医疗保健产业的持续进步以及心血管疾病发生率的上升是推动市场发展的主要动力。

生物材料市场分析：

  • 主要市场驱动因素：肌肉骨骼疾病患者数量的增加是刺激市场的主要驱动因素之一。此外，可溶解缝合线和敷料、缝合钉以及用于伤口闭合的夹子等材料的应用日益增多，也是另一个重要的成长诱因。
  • 主要市场趋势：聚合物合成、蛋白质和胜肽工程、分子自组装和微製造技术的多项进步是推动市场发展的新兴趋势。
  • 地理趋势：由于老年人口不断增长且经常需要医疗干预，北美在整个市场占据明显主导地位。此外，研究机构数量的不断增加和医疗保健基础设施的健全也推动了该地区市场的成长。
  • 竞争格局：根据生物材料市场概况，一些知名公司包括 BASF SE、Berkeley Advanced Biomaterials、Carpenter Technology Corporation、Collagen Matrix Inc.、CoorsTek Inc.、Corbion NV、Dentsply Sirona、Evonik Industries AG、强生、Koninklijke DSM NV、Medker Hlclc、Stryx、Sttrem、Stry 和 Biomett. 等。
  • 挑战与机会：严格的监管架构和繁琐的临床前测试阻碍了市场的发展。然而，随着更具预测性的体内和体外模型在临床使用前用于评估生物相容性，预计将在预测期内扩大市场。

生物材料市场趋势：

3D列印技术的发展

包括3D列印技术在内的创新技术正在改善医疗植入物和医疗器材的设计和製造方式。此外，它们能够生产出传统方法难以或无法实现的患者专属复杂形状。因此，这些技术在牙科、骨科、义肢等解剖精准度至关重要的领域中得到了广泛的应用。这反过来又为生物材料市场带来了利润丰厚的机会之一。例如，2024年2月，Nanavati Max超级专科医院在孟买启用了一个医疗3D列印实验室，以支援高精度手术。这家开创性的机构与肿瘤科紧密结合，提供最先进的精密手术，这些手术需要在重建骨科、肿瘤科和专科牙科手术中精确、细緻地进行。此外，3D列印技术与生物材料广泛融合，用于製造根据患者个体解剖结构量身定制的复杂医疗器材和植入物，在全球范围内正日益受到广泛关注。例如，2023年10月发表的一项研究成果，帮助卑尔根豪克兰大学医院的职业治疗师利用3D列印和扫描技术开发个人化手部矫形器，从而减轻疼痛、最大程度地减少病情恶化、提高患者依从性等。此外，3D列印技术还能够融合具有不同机械性能的梯度材料，这也对市场产生了积极影响。例如，2023年10月，赢创推出了许多医疗应用的植入级长丝和碳纤维增强聚醚醚酮（PEEK）。此外，这些技术还有助于治疗慢性疾病，预计将在未来几年推动生物材料市场的整体发展。例如，2023年7月，透过与韩国生命研究院、韩国机械研究院、科学技术资讯通讯部下属机构的联合研究，推出了全球首个增强自然杀手（NK）免疫细胞功能的3D生物列印技术。

组织工程的创新

组织工程在生物材料研究中扮演重要角色。它在开发用于维持、恢復或改善组织功能的生物替代品方面正日益受到广泛关注。例如，2023年6月，OrganaBio宣布推出NeoPAC胎盘和脐带组织，以加速再生医学和细胞疗法的进展。此外，透过提供仅供研究使用（RUO）和临床级组织，OrganaBio鼓励研究人员挖掘出生组织的潜力，从而开发创新疗法以应对许多疾病。此外，对新型支架（一种经过精心设计，能够引发理想的细胞相互作用，促进新组织形成的材料）的需求不断增长，也推动了市场的发展。例如，2023年6月，组织工程领域的领先创新者之一3DBioFibR推出了两款新型胶原纤维产品，即CollaFibR 3D和μCollaFibR支架。这些产品为组织培养和组织工程应用带来了显着的优势。此外，各机构不断增加对研发活动和研究设施的投资，以实现结构和功能更精准的组织工程，这也为生物材料市场收入做出了贡献。例如，2023年1月，美国国家生物医学影像与生物工程研究所 (NIBIB) 成立了生物医学工程技术加速中心（BETA 中心），这是一个新的内部研究项目，旨在加速尖端技术的验证、开发和传播。该中心专注于生物感测、工程和合成生物学、生物医学成像、奈米材料和生物材料等多个领域。

伤口敷料的应用日益广泛

生物材料在先进伤口敷料中的应用日益广泛，因为它们有助于改善多种伤口（包括急性和慢性损伤）的癒合过程和疗效，这已成为重要的成长驱动因素。此外，一些关键参与者正在开发用于伤口护理的永续材料。例如，2024年3月，科学技术部下属高等科学技术研究所（IASST）的科学家团队推出了由香蕉纤维製成的环保伤口敷料。此外，用于製造这种创新敷料的所有材料均来自当地，且均为天然材料，因此生产过程经济高效、简单无毒。此外，人们对基于生物材料的伤口敷料的日益青睐也推高了生物材料市场的价格。它们可以由各种材料製成，包括泡沫、水凝胶、薄膜等，这些材料通常富含抗菌剂等生物活性物质，以减少感染并促进组织再生。例如，2022年5月，瑞典医疗器材新创公司Amferia AB获得了美国专利商标局（USPTO）授予的一项基础专利，该专利涉及一种基于两亲性抗菌水凝胶的抗菌材料。同时，根据发表在《生物材料进展》杂誌上的研究成果，贝尔法斯特女王大学的一支研究团队于2023年6月设计了一种3D列印绷带（也称为支架），为治疗糖尿病足溃疡（DFU）提供了一种创新方法。

全球生物材料市场细分：

按类型分列：

  • 天然生物材料
  • 金属生物材料
  • 陶瓷生物材料
  • 聚合物生物材料

目前，金属生物材料占据最大的市场份额

此细分市场的成长得益于金属生物材料优异的强度、最佳的耐用性和增强的生物相容性。因此，它们广泛应用于承重应用，包括牙科植体、骨科植入物、心血管器械等。例如，2024年4月，波士顿微製造公司（BMF）宣布其创新型UltraThineer材料获得美国食品药物管理局（FDA）批准。此外，不銹钢、钛、钴铬合金等多种金属因其优异的机械性能而被广泛应用，这些性能可确保其在身体运动压力下的长寿命和弹性。例如，2022年1月，根据《胶体与表面A》杂誌报导，研究人员利用奈米多孔TiO2有效改质TC26合金，以增强人工植入物的骨整合和生物活性。此外，2023年6月，莫斯科科技城经济特区宣布开始生产钛植入物。因此，不断增加的产品应用将在未来几年继续推动金属生物材料市场的需求。

按应用分类：

  • 神经病学
  • 心臟病学
  • 骨科
  • 伤口护理
  • 牙科
  • 整型手术
  • 其他的

耐用的陶瓷、金属和聚合物基材料对于关节置换和骨修復至关重要。此外，它们也用于製造需要与口腔组织具有高相容性和强度的重建器械。此外，包括神经内科和心臟病学在内的关键领域需要生物材料来製造神经植入物、脑机介面、支架、心律调节器等。例如，2022年2月，宾州州立大学伦德奎斯特生物医学创新研究所和加州大学洛杉矶分校的研究人员开发了新型生物材料，以促进血管新生并靶向中风后的免疫反应。根据生物材料市场统计数据，另一类应用涵盖药物传递系统和眼科等其他应用，生物材料分别为植入物和药物控制释放提供客製化解决方案。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美目前占据全球市场份额的主导地位

这份市场研究报告也对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告显示，北美占据了生物材料市场的最大份额。

北美良好的监管环境，尤其是美国食品药物管理局 (FDA) 在支持新生物材料和医疗器材快速审批和开发方面所发挥的作用，正在推动区域市场的发展。例如，2019 年 11 月，DiFusion Inc. 的 Xiphos-ZF 脊椎椎间装置获得了 FDA 批准，该装置基于另一种生物材料 Zfuze，即钛和聚醚醚酮的组合。此外，2023 年 10 月，生物材料平台公司之一 Dimension Inx 宣布 FDA 批准了首款 3D 列印再生骨移植产品 CMFlex。此外，进行脊椎手术的门诊手术中心 (ASC) 数量的不断增长是另一个重要的成长诱导因素。例如，根据 Becker's Healthcare 的资料显示，2023 年 2 月美国有超过 183 个 ASC 进行微创脊椎手术 (MISS)。除此之外，整形手术的日益普及也进一步刺激了区域市场的发展。此外，包括美国国家科学基金会和美国国家标准与技术研究所在内的多个公共和私人组织推出的倡议，为生物材料的使用提供援助，预计将在预测期内推动北美市场的发展。

竞争格局：

市场研究报告对竞争格局进行了全面分析，并提供了所有主要生物材料市场公司的详细资料。市场中的一些主要参与者包括：

  • 巴斯夫
  • 伯克利先进生物材料
  • 卡彭特技术公司
  • 胶原蛋白基质公司
  • CoorsTek公司
  • 科比昂公司
  • 登士柏西诺德
  • 赢创工业股份公司
  • 强生公司
  • 荷兰皇家帝斯曼集团
  • 美敦力公司
  • 史赛克公司
  • 威格斯公司
  • 齐默生物医学公司

本报告回答的关键问题

  • 2024 年全球生物材料市场规模是多少
  • 2025-2033年全球生物材料市场的预期成长率是多少
  • 推动全球生物材料市场的关键因素有哪些
  • COVID-19 对全球生物材料市场有何影响
  • 全球生物材料市场按类型划分如何？
  • 全球生物材料市场的主要区域有哪些
  • 全球生物材料市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球生物材料市场规模？ 2025-2033年全球生物材料市场的预期成长率是多少？
  • 推动全球生物材料市场发展的关键因素有哪些？
  • COVID-19 对全球生物材料市场有何影响？
  • 全球生物材料市场依类型分为哪些类型？
  • 全球生物材料市场的主要区域有哪些？
  • 全球生物材料市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球生物材料市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 天然生物材料
  • 金属生物材料
  • 陶瓷生物材料
  • 聚合物生物材料

第七章：市场区隔：依应用

  • 神经病学
  • 心臟病学
  • 骨科
  • 伤口护理
  • 牙科
  • 整型手术
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第九章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BASF SE
    • Berkeley Advanced Biomaterials
    • Carpenter Technology Corporation
    • Collagen Matrix Inc.
    • CoorsTek Inc.
    • Corbion NV
    • Dentsply Sirona
    • Evonik Industries AG
    • Johnson & Johnson
    • Koninklijke DSM NV
    • Medtronic plc
    • Stryker Corporation
    • Victrex plc
    • Zimmer Biomet
Product Code: SR112025A5892

The global biomaterials market size reached USD 126.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 289.7 Billion by 2033, exhibiting a growth rate (CAGR) of 9.7% during 2025-2033. Continuous advancements in the healthcare industry, along with the rising prevalence of cardiovascular diseases, are primarily propelling the market.

Biomaterials Market Analysis:

  • Major Market Drivers: The increasing number of individuals with musculoskeletal conditions represents one of the primary drivers stimulating the market. Additionally, the rising adoption of these materials in dissolvable sutures and dressings, staples, and clips for wound closure is also acting as another significant growth-inducing factor.
  • Key Market Trends: Several advancements in polymer synthesis, protein and peptide engineering, molecular self-assembly, and microfabrication technologies are among the emerging trends bolstering the market.
  • Geographical Trends: North America exhibits a clear dominance across the market, owing to the expanding geriatric population who often need medical interventions. Moreover, the inflating number of research institutions and robust healthcare infrastructures is impelling the growth of the regional market.
  • Competitive Landscape: As per the biomaterials market overview, some of the prominent companies include BASF SE, Berkeley Advanced Biomaterials, Carpenter Technology Corporation, Collagen Matrix Inc., CoorsTek Inc., Corbion N.V., Dentsply Sirona, Evonik Industries AG, Johnson & Johnson, Koninklijke DSM N.V., Medtronic plc, Stryker Corporation, Victrex plc, and Zimmer Biomet, among many others.
  • Challenges and Opportunities: Stringent regulatory frameworks and extensive preclinical testing are hampering the market. However, the introduction of more predictive in-vivo and in-vitro models to assess biocompatibility before clinical use is expected to augment the market over the forecasted period.

Biomaterials Market Trends:

Development of 3D Printing Technologies

The introduction of novel innovations, including 3D printing technologies, is improving the ways in which medical implants and devices are designed and manufactured. Moreover, they enable the production of patient-specific and complex shapes that are difficult or impossible to achieve with traditional methods. Consequently, these technologies find extensive applications in fields, such as dentistry, orthopedics, prosthetics, etc., where anatomical precision is crucial. This, in turn, is one of the lucrative biomaterials market recent opportunities. For example, in February 2024, Nanavati Max Super Specialty Hospital launched a medical 3D printing laboratory in Mumbai to facilitate high-precision surgeries. This pioneering facility is closely integrated with oncology to offer state-of-the-art precision surgeries that are required to be performed accurately and carefully in reconstructive orthopedic, oncologic, and specialized dentistry surgeries. Additionally, the widespread integration of 3D printing technology in biomaterials for creating customized and complex medical devices and implants tailored to individual patients' anatomies is further gaining extensive traction across the globe. For instance, in October 2023, a study was published that assisted the occupational therapists at the Haukeland University Hospital in Bergen to develop personalized hand orthoses by using 3D printing and scanning technologies, which can reduce pain, minimize deterioration, enhance patient compliance, etc. Apart from this, 3D printing allows for the incorporation of gradients of materials with varying mechanical properties, which is also positively influencing the market. For example, in October 2023, Evonik launched implant-grade filaments and carbon-fiber-reinforced PEEK for numerous medical applications. Furthermore, these technologies assist in the treatment of chronic diseases, which is projected to fuel the overall biomaterials market outlook in the coming years. For example, in July 2023, through joint research with the Korea Research Institute of Bioscience and Biotechnology, the Korea Institute of Machinery and Materials, and the institute under the jurisdiction of the Ministry of Science and ICT launched the world's first 3D bioprinting technology that enhances the function of natural killer (NK) immune cells.

Innovations in Tissue Engineering

Tissue engineering plays an important role in biomaterials research. It is gaining immense popularity for developing biological substitutes to maintain, restore, or improve tissue function. For example, in June 2023, OrganaBio announced the introduction of NeoPAC placenta and umbilical cord tissues that are specifically designed to accelerate the progress of regenerative medicine and cell therapy. Moreover, by providing both Research Use Only (RUO) and clinical-grade tissues, OrganaBio encourages researchers to tap into the potential of birth tissues, thereby enabling the development of innovative therapies to address numerous medical conditions. Apart from this, the rising demand for novel scaffolds that are materials engineered to cause desirable cellular interactions to facilitate the formation of new tissues is also elevating the market. For instance, in June 2023, 3DBioFibR, one of the leading innovators in tissue engineering, released two new collagen fiber products, namely CollaFibR 3D and μCollaFibR scaffold. These variants offer significant benefits for tissue culture and tissue engineering applications. Additionally, the elevating investments in R&D activities and research facilities by various organizations to enable the engineering of more structurally and functionally accurate tissues are contributing to the biomaterials market revenue. For example, in January 2023, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) established the Center for Biomedical Engineering Technology Acceleration (BETA Center), a new intramural research program to accelerate the validation, development, and dissemination of cutting-edge technologies. The center focuses on several areas, such as biosensing, engineered and synthetic biology, biomedical imaging, nanomaterials and biomaterials, etc.

Growing Applications in Wound Dressings

The rising adoption of biomaterials in advanced wound dressings, as they help in improving the healing process and outcomes for numerous types of wounds, including acute and chronic injuries, is acting as a significant growth-inducing factor. Besides this, key players are developing sustainable materials for wound care. For example, in March 2024, a team of scientists at the Institute of Advanced Study in Science and Technology (IASST), under the Department of Science and Technology, introduced an eco-friendly wound dressing material made using banana fibers. Moreover, all the materials utilized in creating this innovative dressing material are locally available and natural, making the manufacturing process cost-effective, simple, and non-toxic. Apart from this, the increasing inclination towards bio-material-based wound dressings is elevating the biomaterials market prices. They can be produced from various materials, including foams, hydrogels, films, etc., that are often imbued with bioactive substances like antimicrobial agents to reduce infection and promote tissue regeneration. For instance, in May 2022, Amferia AB, a Swedish medical device startup, was granted a foundational patent by the U.S. Patent and Trademark Office (USPTO) for an antimicrobial material based on an amphiphilic antimicrobial hydrogel. In line with this, in June 2023, according to the findings published in the Journal of Biomaterials Advances, a team of researchers from Queen's University of Belfast designed a 3D printed bandage, also called a scaffold, which presents an innovative method of treatment to heal diabetic foot ulcers (DFUs).

Global Biomaterials Market Segmentation:

Breakup by Type:

  • Natural Biomaterial
  • Metallic Biomaterial
  • Ceramic Biomaterial
  • Polymeric Biomaterial

Currently, metallic biomaterial accounts for the largest market share

The growth in this segmentation is driven due to exceptional strength, optimal durability, and enhanced biocompatibility exhibited by metallic biomaterials. Consequently, they find extensive load-bearing applications, including dental implants, orthopedic implants, cardiovascular devices, etc. For instance, in April 2024, Boston Micro Fabrication (BMF) announced the U.S. Food and Drug Administration (FDA) clearance for its innovative UltraThineer material. Moreover, several metals, such as stainless steel, titanium, cobalt-chromium alloys, etc., are widely used, owing to their superior mechanical properties that ensure longevity and resilience under the stress of bodily movements. For example, in January 2022, according to the journal Colloids and Surfaces A, researchers efficiently modified a TC26 alloy with nanoporous TiO2 to enhance the osseointegration and bioactivity of artificial implants. In addition to this, in June 2023, Technopolis Moscow SEZ announced the production of titanium implants. As a result, the increasing product applications will continue to drive the metallic biomaterials market demand in the coming years.

Breakup by Application:

  • Neurology
  • Cardiology
  • Orthopedics
  • Wound Care
  • Dental
  • Plastic Surgery
  • Others

Durable ceramic, metallic, and polymer-based materials are essential for joint replacements and bone repair. Moreover, they are adopted in the manufacturing of reconstructive devices that require high compatibility and strength with oral tissues. Apart from this, key areas, including neurology and cardiology, require biomaterials for neural implants, brain-machine interfaces, stents, pacemakers, etc. For instance, in February 2022, Researchers at the Lundquist Institute for Biomedical Innovation, Penn State, and the University of California Los Angeles developed novel biomaterials to promote new blood vessels and target post-stroke immune responses. According to the biomaterials market statistics, the other category encompasses additional applications like drug delivery systems and ophthalmology, where biomaterials offer tailored solutions for implants and controlled medication release, respectively.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America currently dominates the global market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest biomaterials market share.

The favorable regulatory environment in North America, particularly the role of the U.S. Food and Drug Administration (FDA), which supports the rapid approval and development of new biomaterials and medical devices, is fueling the regional market. For example, in November 2019, DiFusion Inc. received FDA approval for its Xiphos-ZF spinal interbody device, which is based on a different biomaterial Zfuze, a combination of titanium and poly-ether-ether-ketone. Additionally, in October 2023, Dimension Inx, one of the biomaterials platform companies, announced the FDA approval of CMFlex, the first 3D-printed regenerative bone graft product. Moreover, the growing number of ambulatory surgical centers (ASCs) that perform spinal surgeries is acting as another significant growth-inducing factor. For instance, in February 2023, according to Becker's Healthcare data showcased that more than 183 ASCs in the United States perform minimally invasive spine surgery (MISS). Apart from this, the inflating popularity of cosmetic surgeries is further stimulating the regional market. In addition, the launch of initiatives undertaken by several public and private organizations, including the National Science Foundation and the National Institute of Standards and Technology, which provide assistance pertaining to biomaterials usage, is expected to fuel the market in North America over the forecasted period.

Competitive Landscape:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major biomaterials market companies have also been provided. Some of the key players in the market include:

  • BASF SE
  • Berkeley Advanced Biomaterials
  • Carpenter Technology Corporation
  • Collagen Matrix Inc.
  • CoorsTek Inc.
  • Corbion N.V.
  • Dentsply Sirona
  • Evonik Industries AG
  • Johnson & Johnson
  • Koninklijke DSM N.V.
  • Medtronic plc
  • Stryker Corporation
  • Victrex plc
  • Zimmer Biomet

Key Questions Answered in This Report

  • 1.What was the size of the global biomaterials market in 2024?
  • 2.What is the expected growth rate of the global biomaterials market during 2025-2033?
  • 3.What are the key factors driving the global biomaterials market?
  • 4.What has been the impact of COVID-19 on the global biomaterials market?
  • 5.What is the breakup of the global biomaterials market based on type?
  • 6.What are the key regions in the global biomaterials market?
  • 7.Who are the key players/companies in the global biomaterials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomaterials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Natural Biomaterial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metallic Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ceramic Biomaterial
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Polymeric Biomaterial
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Orthopedics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Wound Care
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Dental
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Plastic Surgery
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 BASF SE
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Berkeley Advanced Biomaterials
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Carpenter Technology Corporation
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Collagen Matrix Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
    • 13.3.5 CoorsTek Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Corbion N.V.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Dentsply Sirona
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Evonik Industries AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Johnson & Johnson
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Koninklijke DSM N.V.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Medtronic plc
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis
    • 13.3.12 Stryker Corporation
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Victrex plc
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
    • 13.3.14 Zimmer Biomet
      • 13.3.14.1 Company Overview
      • 13.3.14.2 Product Portfolio
      • 13.3.14.3 Financials
      • 13.3.14.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomaterials Market: Major Drivers and Challenges
  • Figure 2: Global: Biomaterials Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biomaterials Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biomaterials Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Biomaterials Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Biomaterials Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Biomaterials (Natural Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Biomaterials (Natural Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Biomaterials (Metallic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biomaterials (Metallic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biomaterials (Ceramic Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biomaterials (Ceramic Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biomaterials (Polymeric Biomaterial) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biomaterials (Polymeric Biomaterial) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biomaterials (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biomaterials (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biomaterials (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biomaterials (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biomaterials (Orthopedics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biomaterials (Orthopedics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Biomaterials (Wound Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Biomaterials (Wound Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Biomaterials (Dental) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Biomaterials (Dental) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Biomaterials (Plastic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Biomaterials (Plastic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Biomaterials (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Biomaterials (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: North America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: North America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: United States: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: United States: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Canada: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Canada: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia-Pacific: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia-Pacific: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: China: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: China: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Japan: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Japan: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: India: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: India: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: South Korea: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: South Korea: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Australia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Australia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Indonesia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Indonesia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Europe: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Europe: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Germany: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Germany: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: France: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: France: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United Kingdom: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United Kingdom: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Italy: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Italy: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Spain: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Spain: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Russia: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Russia: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Latin America: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Latin America: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Brazil: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Brazil: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Mexico: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Mexico: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Middle East and Africa: Biomaterials Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Middle East and Africa: Biomaterials Market: Breakup by Country (in %), 2024
  • Figure 77: Middle East and Africa: Biomaterials Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Biomaterials Industry: SWOT Analysis
  • Figure 79: Global: Biomaterials Industry: Value Chain Analysis
  • Figure 80: Global: Biomaterials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomaterials Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biomaterials Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Biomaterials Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Biomaterials Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Biomaterials Market: Competitive Structure
  • Table 6: Global: Biomaterials Market: Key Players